Literature DB >> 23306453

Hereditary angioedema: a bradykinin-mediated swelling disorder.

Jenny Björkqvist1, Anna Sala-Cunill, Thomas Renné.   

Abstract

Edema is tissue swelling and is a common symptom in a variety of diseases. Edema form due to accumulation of fluids, either through reduced drainage or increased vascular permeability. There are multiple vascular signalling pathways that regulate vessel permeability. An important mediator that increases vascular leak is the peptide hormone bradykinin, which is the principal agent in the swelling disorder hereditary angioedema. The disease is autosomal dominant inherited and presents clinically with recurrent episodes of acute swelling that can be life-threatening involving the skin, the oropharyngeal, laryngeal, and gastrointestinal mucosa. Three different types of hereditary angiodema exist in patients. The review summarises current knowledge on the pathophysiology of hereditary angiodema and focuses on recent experimental and pharmacological findings that have led to a better understanding and new treatments for the disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306453     DOI: 10.1160/TH12-08-0549

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Authors:  K-A Steen Burrell; J Layzer; B A Sullenger
Journal:  J Thromb Haemost       Date:  2017-08-02       Impact factor: 5.824

2.  Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.

Authors:  Evi X Stavrou; Chao Fang; Alona Merkulova; Omar Alhalabi; Nadja Grobe; Silvio Antoniak; Nigel Mackman; Alvin H Schmaier
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

3.  Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Authors:  Jenny Björkqvist; Steven de Maat; Urs Lewandrowski; Antonio Di Gennaro; Chris Oschatz; Kai Schönig; Markus M Nöthen; Christian Drouet; Hal Braley; Marc W Nolte; Albert Sickmann; Con Panousis; Coen Maas; Thomas Renné
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

4.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 5.  The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.

Authors:  Marie Worm; Elodie C Köhler; Rachita Panda; Andy Long; Lynn M Butler; Evi X Stavrou; Katrin F Nickel; Tobias A Fuchs; Thomas Renné
Journal:  Ann Transl Med       Date:  2015-10

Review 6.  Pathophysiology of Hereditary Angioedema.

Authors:  Sonia Caccia; Chiara Suffritti; Marco Cicardi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-12-01       Impact factor: 1.349

Review 7.  Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.

Authors:  Marc Riedl
Journal:  Clin Drug Investig       Date:  2015-07       Impact factor: 2.859

8.  A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.

Authors:  Delphine Gobert; Romain Paule; Denise Ponard; Pierre Levy; Véronique Frémeaux-Bacchi; Laurence Bouillet; Isabelle Boccon-Gibod; Christian Drouet; Stéphane Gayet; David Launay; Ludovic Martin; Arsène Mekinian; Véronique Leblond; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Enzymatic assays for the diagnosis of bradykinin-dependent angioedema.

Authors:  Federica Defendi; Delphine Charignon; Arije Ghannam; Remi Baroso; Françoise Csopaki; Marion Allegret-Cadet; Denise Ponard; Bertrand Favier; Sven Cichon; Brigitte Nicolie; Olivier Fain; Ludovic Martin; Christian Drouet
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.

Authors:  Stefania Loffredo; Anne Lise Ferrara; Maria Bova; Francesco Borriello; Chiara Suffritti; Nóra Veszeli; Angelica Petraroli; Maria Rosaria Galdiero; Gilda Varricchi; Francescopaolo Granata; Andrea Zanichelli; Henriette Farkas; Marco Cicardi; Gérard Lambeau; Gianni Marone
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.